Imaging ONE WORLD - "Chemical Microscopy - Making the Invisible Visible and Vice Versa"
23 November 2020
This week will feature Sapun Parekh from The University of Texas at Austin. Sapun will present his talk titled "Chemical Microscopy - making the invisible visible and vice versa."
Scientific Organisers: Stefanie Reichelt, Alex Sossick, Nick Barry, Alessandro Esposito and Kirti Prakash
The meeting will begin at 1pm UK Time.
As part of the 'Imaging ONE WORLD' series, the focus of these lectures is on microscopy and image analysis methods and how to apply these to your research. Almost all aspects of imaging such as sample preparation, labelling strategies, experimental workflows, ‘how-to’ image and analyse, as well as facilitating collaborations and inspiring new scientific ideas will be covered. Speakers will be available for questions and answers. The organisers, CRUK CI core facility staff, Gurdon Institute, MRC-LMB, MRC Cancer Unit and NPL will be able to continue the discussion and provide advice on your imaging projects.
University of Texas at Austin
Sapun Parekh is an Assistant Professor in the Department of Biomedical Engineering at UT Austin and an Adjunct Group Leader in the Molecular Spectroscopy Department at the Max Planck Institute for Polymer Research. He received his BS in Electrical Engineering from the University of Texas at Austin in 2002 and completed his PhD in Bioengineering from the University of California at Berkeley/San Francisco in 2008 where he focused on force generation and mechanics of semi-flexible actin networks. He then completed a postdoctoral period (2008-2010) in the Biomaterials Group at the National Institute for Standards and Technology where he worked on mechanobiology of stem cell differentiation and development of label-free imaging techniques. The Parekh lab conducts research on the molecular organization and biophysics of pathology using nonlinear microscopy and label-free imaging. His lab seeks to understand how molecular changes in cells and tissues are indicators, or possibly predictors, of aberrant physiological outcomes. Central to our work is the development and use of in situ advanced molecular microscopy methods and data driven analyses.